Martin Nicklasson

Martin Nicklasson 0293

Chair of the Board

Elected to the Board in 2015 and regarded as an independent board member.

  • Chair of the Remuneration Committee 
  • Member of the Audit Committee
  • Member of the Nomination Committee

Special competencies

Extensive general management and research and development experience from AstraZeneca Plc and Swedish Orphan Biovitrum AB.

Current positions

Board member of Basilea Pharmaceutica Ltd. and chairman of Nykode Therapeutics AS.

Share profile